Abstract
Precision medicine combines genetic, environmental and lifestyle variability to inform disease diagnosis, treatment and prevention, allowing exact medical interventions both on individual and population levels. Data-driven precision medicine measures constitute an informational intervention that is dynamic in time, space and in terms of actors and groups involved, as well as regarding the relevance of results and the causality of decisions. Correspondingly, normative guidance for decision making is characterised by strong proceduralisation. When justifying data processing, the changing role of patients in relation to data processing needs to be respected. It not only influences the design of informed consent, but significantly impacts data security in response to identified risks. Further issues in precision medicine include dealing with anonymisation as well as the return of research results. New tools such as machine learning and its application through neurotechnologies pose challenges to patients’ autonomy, benefit production, sharing, justice and equity. In response to the need for dynamic guidance to engage with these particular challenges, procedural measures and tools framing conduct of precision medicine have emerged, including codes of conduct, closer ethics committee scrutiny and data stewardship models. These tools enable ethics-by-design and contribute to coordination between ethical and legal rules.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
An extensive reappraisal of the scholarly literature on dealing with additional findings and the return of results of (translational) research, including its semantic description, cannot possibly be reproduced here. For examples, cf. Wolf et al., 2008; Knoppers & Dam, 2011; Hayden, 2012; Green et al., 2013; Zawati et al., 2014; Pereira et al., 2016; Wolf & Evans, 2018; Dyke et al., 2019; Clayton et al., 2021.
- 2.
- 3.
Codes of Conduct are also anchored in EU data protection law, cf. Art. 40 of the EU General Data Protection Regulation (GDPR).
- 4.
Cf. Recital 33 of the GDPR. According to this (non-binding) provision, data subjects should be allowed to give their consent to certain areas of scientific research when in keeping with recognised ethical standards for scientific research. Hereby, compliance with recognized ethical standards can be fulfilled by adhering to ethics committees’ authorisation of the research planned.
- 5.
Proposal for a Regulation of the European Parliament and of the Council on European data governance (Data Governance Act). COM/2020/767 final. https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:52020PC0767&from=EN
References
Alami, H., Rivard, L., Lehoux, P., Hoffman, S. J., Cadeddu, S., Savoldelli, M., Samri, M. A., Ag Ahmed, M. A., Fleet, R., & Fortin, J. P. (2020). Artificial intelligence in health care: Laying the foundation for responsible, sustainable, and inclusive innovation in low- and middle-income countries. Globalization and Health, 16, 52.
Ashcroft, R. (2008). The troubled relationship between bioethics and human rights. In M. Freeman (Ed.), Law and bioethics – Current legal issues (Vol. 11, pp. 33–51). Oxford University Press.
Auffray, C., Chen, Z., & Hood, L. (2009). Systems medicine: The future of medical genomics and healthcare. Genome Medicine, 1, 2.
Ballantyne, A. (2019). Adjusting the focus: A public health ethics approach to data research. Bioethics, 33, 357–366.
Ballantyne, A., & Stewart, C. (2019). Big data and public-private partnerships in healthcare and research. Asian Bioethics Review, 11, 315–326.
Batten, J. N. (2018). How stratification unites ethical issues in precision health. AMA Journal of Ethics, 20, 798–803.
Beckmann, J. S., & Lew, D. (2016). Reconciling evidence-based medicine and precision medicine in the era of big data: Challenges and opportunities. Genome Medicine, 8, 134.
Bell, J. L. (2020). Governing commercial access to health data for public benefit: Charity law solutions. Med Law Rev, 28(2), 247–269.
Benke, K., & Benke, G. (2018). Artificial intelligence and big data in public health. International Journal of Environmental Research and Public Health, 15(12), 2796.
Berger, M. F., & Mardis, E. R. (2018). The emerging clinical relevance of genomics in cancer medicine. Nature Reviews Clinical Oncology, 15, 353–365.
Borry, P., Schotsmans, P., & Dierickx, K. (2005). The birth of the empirical turn in bioethics. Bioethics, 19(1), 49–71.
Brothers, K. B., & Rothstein, M. A. (2015). Ethical, legal and social implications of incorporating personalized medicine into healthcare. Personalized Medicine, 12, 43–51.
Brouillette, M. (2019). AI added to the curriculum for doctors-to-be. Nature Medicine, 25, 1808–1809.
Brownsword, R. (2004). The cult of consent: Fixation and Fallacy. King’s Law Journal, 15, 223–251.
Bunnik, E. M., Janssens, A. C., & Schermer, M. H. (2013). A tiered-layered-staged model for informed consent in personal genome testing. European Journal of Human Genetics, 21, 596–601.
Bunnik, E. M., Dondorp, W. J., Bredenoord, A. L., de Wert, G., & Cornel, M. C. (2021). Mainstreaming informed consent for genomic sequencing: A call for action. European Journal of Cancer, 148, 405–410.
Bygrave, L. (2014). Data privacy law: In international perspective. Oxford University Press.
Campbell, A. V., Chin, J., & Voo, T. C. (2007). How can we know that ethics education produces ethical doctors? Medical Teacher, 29, 431–436.
Carter, C. S., Bearden, C. E., Bullmore, E. T., Geschwind, D. H., Glahn, D. C., Gur, R. E., Meyer-Lindenberg, A., & Weinberger, D. R. (2017). Enhancing the Informativeness and replicability of imaging genomics studies. Biological Psychiatry, 82, 157–164.
Chalmers, D., Nicol, D., Nicolás, P., & Zeps, N. (2014). A role for research ethics committees in exchanges of human biospecimens through material transfer agreements. Bioethical Inquiry, 11, 301–306.
Chang, H., Hoshina, N., Zhang, C., Ma, Y., Cao, H., Wang, Y., Wu, D. D., Bergen, S. E., Landén, M., Hultman, C. M., Preisig, M., Kutalik, Z., Castelao, E., Grigoroiu-Serbanescu, M., Forstner, A. J., Strohmaier, J., Hecker, J., Schulze, T. G., Müller-Myhsok, B., Reif, A., & Li, M. (2018). The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders. Molecular Psychiatry, 23, 400–412.
Christman, J. (2011). The politics of persons. Individual autonomy and sociohistorical selves. Cambridge University Press.
Claussnitzer, M., Cho, J. H., Collins, R., et al. (2020). A brief history of human disease genetics. Nature, 577, 179–189.
Clayton, E. W., Appelbaum, P. S., Chung, W. K., Marchant, G. E., Roberts, J. L., & Evans, B. J. (2021). Does the law require reinterpretation and return of revised genomic results? Genetics in Medicine, 23, 833–836.
Collins, F. S. (1999). Medical and societal consequences of the human genome project. New England Journal of Medicine, 341, 28–37.
Cooper, L. A., Ortega, A. N., Ammerman, A. S., Buchwald, D., Paskett, E. D., Powell, L. H., Thompson, B., Tucker, K. L., Warnecke, R. B., McCarthy, W. J., Viswanath, K. V., Henderson, J. A., Calhoun, E. A., & Williams, D. R. (2015). Calling for a bold new vision of health disparities intervention research. American Journal of Public Health, 105(Suppl 3), S374–S376.
Courtland, R. (2018). Bias detectives: The researchers striving to make algorithms fair. Nature, 558(7710), 357–360.
Datenschutzkonferenz. (2019). Beschluss der 97. Konferenz der unabhängigen Datenschutzaufsichtsbehörden des Bundes und der Länder zu Auslegung des Begriffs „bestimmte Bereiche wissenschaftlicher Forschung“ im Erwägungsgrund 33 der DS-GVO. https://www.datenschutzkonferenz-online.de/media/dskb/20190405_auslegung_bestimmte_bereiche_wiss_forschung.pdf
DeCamp, M., & Lindvall, C. (2020). Latent bias and the implementation of artificial intelligence in medicine. Journal of the American Medical Informatics Association, 27, 2020–2023.
Delacroix, S., & Montgomery, J. (2020). From research data ethics principles to practice: Data trusts as a governance tool.
Donchin, A. (2000). Autonomy and interdependence. Quandaries in genetic decision making. In C. Mackenzie & N. Stoljar (Eds.), Relational autonomy. Feminist perspectives on autonomy, agency, and the social self (pp. 236–258). Oxford University Press.
Dyke, S., Saulnier, K. M., Dupras, C., Webster, A. P., Maschke, K., Rothstein, M., Siebert, R., Walter, J., Beck, S., Pastinen, T., & Joly, Y. (2019). Points-to-consider on the return of results in epigenetic research. Genome Medicine, 11, 31.
Famenka, A., Gibson, S., & Molnár-Gábor, F. (2016). Understanding the complexity of regulation in an evolving health technology landscape. In M. Dreyer, J. Erdmann, & C. Rehman-Sutter (Eds.), Genetic transparency? Ethical and social implications of next generation human genomics and genetic medicine (pp. 193–235). Brill Rodopi.
Fenech, M., Strukelj, N., Buston, O., & Future Advocacy. (2018). Ethical, social and political challenges of artificial intelligence in health. A report with the Wellcome trust. https://wellcome.ac.uk/sites/default/files/ai-in-health-ethical-social-political-challenges.pdf
Ferretti, A., Ienca, M., Hurst, S., & Vayena, E. (2020). Big data, biomedical research, and ethics review: New challenges for IRBs. Ethics & Human Research, 42, 17–28.
Ferryman, K., & Pitcan, M. (2018). Fairness in precision medicine, data & society. https://datasociety.net/wp-content/uploads/2018/02/DataSociety_Fairness_In_Precision_Medicine_Feb2018.pdf
Fischer, T., Brothers, K. B., Erdmann, P., & Langanke, M. (2016). Clinical decision-making and secondary findings in systems medicine. BMC Medical Ethics, 17(1), 32.
Fisher, C. B., & Layman, D. M. (2018). Genomics, big data, and broad consent: A new ethics frontier for prevention science. Prevention Science: The Official Journal of the Society for Prevention Research, 19(7), 871–879.
Ford, E., Boyd, A., Bowles, J., Havard, A., Aldridge, R. W., Curcin, V., Greiver, M., Harron, K., Katikireddi, V., Rodgers, S. E., & Sperrin, M. (2019). Our data, our society, our health: A vision for inclusive and transparent health data science in the United Kingdom and beyond. Learning Health Systems, 3, e10191.
Forgó, N., Kollek, R., Arning, M., Krügel, T., & Petersen, M. (2010). Ethical and legal requirements for transnational genetic research. C.H. Beck.
Forsberg, J. S., Hansson, M. G., & Eriksson, S. (2009). Changing perspectives in biobank research: From individual rights to concerns about public health regarding the return of results. European Journal of Human Genetics, 17(12), 1544–1549.
Gertler, B. (2020). Self-knowledge. In E. N. Zalte (Ed.), The Stanford encyclopedia of philosophy (Spring 2020 Ed.). Stanford University. https://plato.stanford.edu/archives/spr2020/entries/self-knowledge/
Goetz, L. H., & Schork, N. J. (2018). Personalized medicine: Motivation, challenges, and progress. Fertility and Sterility, 109, 952–963.
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., Rehm, H. L., Watson, M. S., Williams, M. S., Biesecker, L. G., & American College of Medical Genetics and Genomics. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565–574.
Haga, S. B. (2017). Overview of policy, ethical, and social considerations in genomic and personalized medicine. In S. P. David (Ed.), Genomic and precision medicine (pp. 19–43). Elsevier.
Haley, B., & Roudnicky, F. (2020). Functional genomics for cancer drug target discovery. Cancer Cell, 38, 31–43.
Hayden, E. C. (2012). DNA donor rights affirmed. Nature, 483, 387.
Hermstrüwer, Y. (2016). Informationelle Selbstgefährdung. Mohr Siebeck.
Heyen, N. B. (2012). Gendiagnostik als Therapie, Die Behandlung von Unsicherheit in der prädiktiven genetischen Beratung. C.H. Beck.
Hilgartner, S., Prainsack, B., & Hurlbut, J. B. (2017). Ethics as governance in genomics and beyond. In U. Felt, R. Fouché, C. A. Miller, & L. Smith-Doerr (Eds.), The handbook of science and technology studies (4th ed., pp. 823–852). The MIT Press.
House of Lords. Select Committee on Artificial Intelligence. (2018). AI in the UK: Ready, willing and able?. HL Paper 100. https://publications.parliament.uk/pa/ld201719/ldselect/ldai/100/100.pdf
Hulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D. A., & McKinney, E. F. (2019). From big data to precision medicine. Frontiers in Medicine, 6, 34.
Hunt, P. W. (2018). The clinical-translational physician-scientist: Translating Bedside to Bench. The Journal of Infectious Diseases, 218, 12–15.
Huntsman, D. G., & Ladanyi, M. (2018). The molecular pathology of cancer: From pan-genomics to post-genomics. The Journal of Pathology, 244, 509–511.
Hurst, S. (2010). What ‘empirical turn in bioethics’? Bioethics, 24, 439–444.
Ienca, M., & Ignatiadis, K. (2020). Artificial intelligence in clinical neuroscience: Methodological and ethical challenges. AJOB Neuroscience, 11, 77–87.
Jonsson, J. J., & Stefansdottir, V. (2019). Ethical issues in precision medicine. Annals of Clinical Biochemistry, 56, 628–629.
Joyner, M. J., & Paneth, N. (2019). Promises, promises, and precision medicine. Journal of Clinical Investigation, 129, 946–948.
Juengst, E. T., & McGowan, M. L. (2018). Why does the shift from “personalized medicine” to “precision health” and “wellness genomics” matter? AMA Journal of Ethics, 20, 881–890.
Juengst, E. T., & Van Rie, A. (2020). Transparency, trust, and community welfare: Towards a precision public health ethics framework for the genomics era. Genome Medicine, 12, 98.
Kao, C. (2018). Illustratio. AMA Journal of Ethics, 20, 793–910. https://journalofethics.ama-assn.org/sites/journalofethics.ama-assn.org/files/2021-08/joe-1809.pdf
Kaye, J., Meslin, E. M., Knoppers, B. M., Juengst, E. T., Deschênes, M., Cambon-Thomsen, A., Chalmers, D., De Vries, J., Edwards, K., Hoppe, N., Kent, A., Adebamowo, C., Marshall, P., & Kato, K. (2012). Research priorities. ELSI 2.0 for genomics and society. Science (New York, N.Y.), 336, 673–674.
Kaye, J., Whitley, E. A., Lund, D., Morrison, M., Teare, H., & Melham, K. (2015). Dynamic consent: A patient interface for twenty-first century research networks. European Journal of Human Genetics, 23, 141–146.
Kellmeyer, P. (2021). Big brain data: On the responsible use of brain data from clinical and consumer-directed neurotechnological devices. Neuroethics, 14, 83–98.
Kellmeyer, P., Cochrane, T., Müller, O., Mitchell, C., Ball, T., Fins, J. J., & Biller-Andorno, N. (2016). The effects of closed-loop medical devices on the autonomy and accountability of persons and systems. Cambridge Quarterly of Healthcare Ethics, 25, 623–633.
Khoury, M. J., Iademarco, M. F., & Riley, W. T. (2016). Precision public health for the era of precision medicine. American Journal of Preventive Medicine, 50, 398–401.
Knoppers, B. M., & Dam, A. (2011). Return of results: towards a lexicon?. The Journal of Law, Medicine & Ethics, 39, 577–582. https://doi.org/10.1111/j.1748-720X.2011.00624.x
Knowles, L. P. (2001). The Lingua Franca of human rights and the rise of a global bioethics. Cambridge Quarterly of Healthcare Ethics, 10, 253–263.
Kollek, R., & Lemke, T. (2008). Der medizinische Blick in die Zukunft: Gesellschaftliche Implikationen prädiktiver Tests. Campus.
Konstantinidou, M. K., Karaglani, M., Panagopoulou, M., Fiska, A., & Chatzaki, E. (2017). Are the origins of precision medicine found in the corpus Hippocraticum? Molecular Diagnosis & Therapy, 21(6), 601–606.
Kwak, S. N., & Park, J. M. (2016). Length-weight and length-length relationships for six flounder species (Pleuronectiformes) from the eastern coast of Korea. Journal of Applied Ichthyology, 32, 160–162.
Lacaze, P., & Baynam, G. (2019). Editorial: Public health genomics. Frontiers in Public Health, 7, 142.
Lavazza, A. (2018). Freedom of thought and mental integrity: The moral requirements for any neural prosthesis. Frontiers in Neuroscience, 12, 82.
Lecaros, J. A. (2019). Biolaw and bioethics: Convergences and divergences. In E. Valdés & J. Lecaros (Eds.), Biolaw and policy in the twenty-first century (pp. 93–118). Springer.
Lee, S. S. (2021). The ethics of consent in a shifting genomic ecosystem. Annual Review of Biomedical Data Science, 4, 145–164.
Lyon, G. J. (2012). There is nothing ‘incidental’ about unrelated findings. Personalized Medicine, 9, 163–166.
Maclean, A. (2009). Autonomy, informed consent and medical law. A relational challenge. Cambridge University Press.
Mandal, J., Ponnambath, D. K., & Parija, S. C. (2017). Ethics of translational medical research. Tropical Parasitology, 7, 62–64.
Manson, N., & O’Neill, O. (2012). Rethinking informed consent in bioethics. Cambridge University Press.
Martinez-Martin, N., Luo, Z., Kaushal, A., Adeli, E., Haque, A., Kelly, S. S., Wieten, S., Cho, M. K., Magnus, D., Fei-Fei, L., Schulman, K., & Milstein, A. (2021). Ethical issues in using ambient intelligence in health-care settings. The Lancet. Digital Health, 3, 115–123.
Mayer-Schönberger, V. (2009). Delete: The virtue of forgetting in the digital age. Princeton University Press.
McGuire, A. L., & Beskow, L. M. (2010). Informed consent in genomics and genetic research. Annual Review of Genomics and Human Genetics, 11, 361–381.
Meagher, K., Mcgowan, M., Settersten, R., Fishman, J., & Juengst, E. (2017). Precisely where are we going? Charting the new terrain of precision prevention. Annual Review of Human of Genomics and Human Genetics, 18, 369–387.
Minari, J., Brothers, K. B., & Morrison, M. (2018). Tensions in ethics and policy created by National Precision Medicine Programs. Human Genomics, 12, 22.
Mittelstadt, B. (2017). The doctor will not see you now. In P. Otto & E. Gräf (Eds.), 3TH1CS: A reinvention of ethics in the digital age? (pp. 68–77). iRights Media.
Molnár-Gábor, F. (2017). Die internationale Steuerung der Biotechnologie am Beispiel des Umgangs mit neuen genetischen Analysen. Duncker und Humblot.
Molnár-Gábor, F. (2019). Das Recht auf Nichtwissen – Fragen einer Verrechtlichung im Kontext von Big Data in der modernen Biomedizin. In G. Duttge & C. Lenk (Eds.), Das sogenannte Recht auf Nichtwissen: Normatives Fundament und anwendungspraktische Geltungskraft (pp. 83–117). Mentis.
Molnár-Gábor, F. (2021). Ausgestaltung der Einwilligung in die Datenspende für die Gesundheitsforschung. Datenschutz Datensich 45, 799–805.
Molnár-Gábor, F. (2023). Schutz der Rechte und Freiheiten von Personen bei der Datenverarbeitung im Gesundheitsbereich: Der Risikoansatz der EU-Datenschutz-Grundverordnung (DGSVO). Bundesgesundheitsbl 66, 143–153.
Molnár-Gábor, F., & Korbel, J. O. (2017). Regulierung neuer Herausforderungen in den Naturwissenschaften – Datenschutz und Datenaustausch in der translationalen genetischen Forschung. In M. Schweiker, J. Hass, A. Novokhatko, & R. Halbleib (Eds.), Messen und Verstehen in der Wissenschaft: Interdisziplinäre Ansätze (pp. 151–171). Springer.
Molnár-Gábor, F., & Korbel, J. O. (2020). Genomic data sharing in Europe is stumbling—Could a code of conduct prevent its fall? EMBO Molecular Medicine, 12, e11421.
Molnár-Gábor, F., & Merk, A. (2021). Spotlight: Die datenschutzrechtliche Bewertung von Neurodaten. In F. Gentechnologiebericht (Ed.), Berlin-Brandenburgische Akademie der Wissenschaften (pp. 221–231). Nomos.
Molnár-Gábor, F., & Weiland, J. (2014). Die Totalsequenzierung des menschlichen Genoms als medizinischer Eingriff. Zeitschrift für medizinische Ethik, 60, 135–147.
Molnár-Gábor, F., Gantner, G., & Lichter, P. (2014). Das Ende der Zufallsbefunde in der genetischen Diagnostik: Die Ganzgenomsequenzierung und die Erwartbarkeit zusätzlicher Befunde. Zeitschrift für Medizin-Ethik-Recht, 2, 81–104.
Moore, J. B. (2020). From personalised nutrition to precision medicine: the rise of consumer genomics and digital health. The Proceedings of the Nutrition Society, 79(3), 300–310.
Mourby, M. (2020). Anonymity in EU Health Law: Not an alternative to information governance. Medical Law Review, 28(3), 478–501.
Muller, S. H. A., Kalkman, S., van Thiel, G. J. M. W. et al. (2021). The social licence for data-intensive health research: towards cocreation, public value and trust. BMC Medical Ethics, 22, 110.
Nuffield Council on Bioethics (2018). Artificial Intelligence (AI) in healthcare and research. Bioethics Briefing Note. https://www.nuffieldbioethics.org/publications/ai-in-healthcare-and-research. Accessed 02 Nov 2021.
O’Neill, O. (2003). Some limits of informed consent. Journal of Medical Ethics, 29(1), 4–7.
Pereira, S., Robinson, J. O., & McGuire, A. L. (2016). Return of individual genomic research results: what do consent forms tell participants? European Journal of Human Genetics, 24(11) 1524–1529.
Petrini, C. (2011). From bench to bedside and to health policies: Ethics in translational research. La Clinica Terapeutica, 162, 51–59.
Pirih, N., & Kunej, T. (2018). An updated taxonomy and a graphical summary tool for optimal classification and comprehension of omics research. Omics: A Journal of Integrative Biology, 22, 337–353.
Prictor, M., Teare, H., Bell, J., Taylor, M., & Kaye, J. (2019). Consent for data processing under the general data protection regulation: Could ‘dynamic consent’ be a useful tool for researchers? Journal of Data Protection & Privacy, 3, 93–112.
Prosperi, M., Min, J. S., Bian, J., & Modave, F. (2018). Big data hurdles in precision medicine and precision public health. BMC Medical Informatics and Decision Making, 18, 139.
Purtova, N. (2018). The law of everything. Broad concept of personal data and future of EU data protection law. Law, Innovation and Technology, 10, 40–81.
Rainey, S., McGillivray, K., Akintoye, S., Fothergill, T., Bublitz, C., & Stahl, B. (2020). Is the European data protection regulation sufficient to deal with emerging data concerns relating to neurotechnology? Journal of Law and the Biosciences, 7, 1–19.
Ray, S., & Srivastava, S. (2020). COVID-19 pandemic: Hopes from proteomics and multiomics research. Omics: A Journal of Integrative Biology, 24, 457–459.
Reeves, B., Ram, N., Robinson, T. N., Cummings, J. J., Giles, C. L., Pan, J., Chiatti, A., Cho, M. J., Roehrick, K., Yang, X., Gagneja, A., Brinberg, M., Muise, D., Lu, Y., Luo, M., Fitzgerald, A., & Yeykelis, L. (2021). Screenomics: A framework to capture and analyze personal life experiences and the ways that technology shapes them. Human-computer Interaction, 36, 150–201.
Rehmann-Sutter, C. (2000). DNA-Horoskope. In M. Düwell & D. Mieth (Eds.), Ethik in der Humangenetik. Die neueren Entwicklungen der genetischen Frühdiagnostik aus ethischer Perspektive (pp. 415–443). Francke.
Rehmann-Sutter, C. (2012). Das ganze Genom. Ethische Überlegungen zur vollständigen Sequenzierung der individuellen DNA. In C. R. Bartram, M. Bobbert, D. Dölling, T. Fuchs, G. Schwarzkopf, & K. Tanner (Eds.), Der (un)durchsichtige Mensch. Wie weit reicht der Blick in die Person? (pp. 255–280). Winter.
Rinik, C. (2020). Data trusts: More data than trust? The perspective of the data subject in the face of a growing problem. International Review of Law, Computers and Technology, 34(3), 342–363.
Rosen, D. L., Buchbinder, M., Juengst, E., & Rennie, S. (2020). Public health research, practice, and ethics for justice-involved persons in the big data era. American Journal of Public Health, 110, 37–38.
Safdar, N. M., Banja, J. D., & Meltzer, C. C. (2020). Ethical considerations in artificial intelligence. European Journal of Radiology, 122, 108768.
Sarajlic, E. (2015). Do predictive brain implants threaten Patient’s autonomy or authenticity? American Journal of Bioethics Neuroscience, 6, 30–32.
Schaefer, G. O., Tai, E. S., & Sun, S. (2019). Precision medicine and big data: The application of an ethics framework for big data in health and research. Asian Bioethics Review, 11, 275–288.
Schulz, P. J., & Nakamoto, K. (2013). Patient behavior and the benefits of artificial intelligence: The perils of “dangerous” literacy and illusory patient empowerment. Patient Education and Counseling, 92(2), 223–228.
Seyhan, A. A. (2019). Lost in translation: The valley of death across preclinical and clinical divide – Identification of problems and overcoming obstacles. Translational Medicine Communications, 4, 18.
Sharkey, A., & Sharkey, N. (2012). Granny and the robots: ethical issues in robot care for the elderly. Ethics and Information Technology, 14, 27–40.
Sheehan, M., Thompson, R., Fistein, J., Davies, J., Dunn, M., Parker, M., Savulescu, J., & Woods, K. (2019). Authority and the future of consent in population-level biomedical research. Public Health Ethics, 12, 225–236.
Sperling, D. (2008). A rights-based relationship and its troubling implications. In M. Freeman (Ed.), Law and bioethics – Current legal issues (Vol. 11, pp. 52–78). Oxford University Press.
Steinsbekk, K., Kåre Myskja, B., & Solberg, B. (2013). Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem? European Journal of Human Genetics, 21, 897–902.
Tabor, H. K., Berkman, B. E., Hull, S. C., & Bamshad, M. J. (2011). Genomics really gets personal: How exome and whole genome sequencing challenge the ethical framework of human genetics research. American Journal of Medical Genetics, Part A, 155, 2916–2924.
Tada, H., Takamura, M., & Kawashiri, M. A. (2020). Genomics of hypertriglyceridemia. Advances in Clinical Chemistry, 97, 141–169.
Tan, A., Huang, H., Zhang, P., & Li, S. (2019). Network-based cancer precision medicine: A new emerging paradigm. Cancer Letters, 458, 39–45.
Tanner, K., Kirchhof, P., von Schulenburg, J., Wolfrum, R., Gantner, G., Molnár-Gábor, F., Frank, M., & Plöthner, M. (2016). Genomanalysen als Informationseingriff. Ethische, juristische und ökonomische Analysen zum prädiktiven Potential der Genomsequenzierung. Winter.
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. (2020). Pan-cancer analysis of whole genomes. Nature, 578, 82–93.
Valdés, E. (2019). Towards a new conception of biolaw. In E. Valdés & J. Lecaros (Eds.), Biolaw and policy in the twenty-first century (pp. 41–58). Springer.
Vos, S., van Delden, J. J. M., van Diest, P. J., & Bredenoord, A. L. (2017). Moral duties of genomics researchers: Why personalized medicine requires a collective approach. Trends in Genetics, 33, 118–128.
Webb, C. P., & Pass, H. I. (2004). Translation research: From accurate diagnosis to appropriate treatment. Journal of Translational Medicine, 2, 35.
Weijer, C., Goldsand, G., & Emanuel, E. J. (1999). Protecting communities in research: Current guidelines and limits of extrapolation. Nature Genetics, 23, 275–280.
Wiens, J., Saria, S., Sendak, M., et al. (2019). Do no harm: A roadmap for responsible machine learning for health care. Nature Medicine, 25, 1337–1340.
Wolf, S. M., & Evans, B. J. (2018). Return of results and data to study participants. Science (New York, N.Y.), 362(6411), 159–160.
Wolf, S. M., Lawrenz, F. P., Nelson, C. A., Kahn, J. P., Cho, M. K., Clayton, E. W., Fletcher, J. G., Georgieff, M. K., Hammerschmidt, D., Hudson, K., Illes, J., Kapur, V., Keane, M. A., Koenig, B. A., Leroy, B. S., McFarland, E. G., Paradise, J., Parker, L. S., Terry, S. F., Van Ness, B., et al. (2008). Managing incidental findings in human subjects research: Analysis and recommendations. The Journal of Law, Medicine & Ethics, 36, 219–248.
Wolf, S. M., Burke, W., & Koenig, B. A. (2015). Mapping the ethics of translational genomics: Situating return of results and navigating the research-clinical divide. The Journal of Law, Medicine & Ethics, 43, 486–501.
World Health Organization. (2019). Recommendations on digital interventions for health system strengthening [Licence: CC BY-NC-SA 3.0 IGO.]. https://apps.who.int/iris/bitstream/handle/10665/311941/9789241550505-eng.pdf?ua=1
Yuste, R., Goering, S., Arcas, B., Bi, G., Carmena, J. M., Carter, A., Fins, J. J., Friesen, P., Gallant, J., Huggins, J. E., Illes, J., Kellmeyer, P., Klein, E., Marblestone, A., Mitchell, C., Parens, E., Pham, M., Rubel, A., Sadato, N., Sullivan, L. S., et al. (2017). Four ethical priorities for neurotechnologies and AI. Nature, 551, 159–163.
Zawati, M. H., Parry, D., & Knoppers, B. M. (2014). The best interests of the child and the return of results in genetic research: International comparative perspectives. BMC Medical Ethics, 15, 72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Molnár-Gábor, F. (2023). Precision Medicine. In: Valdés, E., Lecaros, J.A. (eds) Handbook of Bioethical Decisions. Volume I. Collaborative Bioethics, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-031-29451-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-031-29451-8_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-29450-1
Online ISBN: 978-3-031-29451-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)